Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Recruiting · NCT07400926 · Observational (researchers observe without assigning treatment) · Lead sponsor: Glaukos Corporation
View the official record on ClinicalTrials.gov →Interventions studied
Travoprost
What this trial is about
Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Diagnosis of Open-angle glaucoma
- 18 years of age or older
Exclusion criteria
- Subject who is breast-feeding or pregnant
Where it is running
1 location listed across 1 US state.
- Glaukos Investigative Site - Kenosha, Wisconsin, United States